Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US1143401024
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG000DX9JV7
AZTA
Azenta Inc
GICS: Information Technology · SECTOR: EQTY · SUB-SECTOR: Medical Instruments & Supplies · THEMEFOLIO: $HLTH
NAME
Azenta Inc
ISIN
US1143401024
TICKER
AZTA
MIC
XNAS
REUTERS
AZTA.OQ
BLOOMBERG
AZTA US
Tue, 03.11.2026       Azenta
US1143401024

NEW YORK, Nov. 3, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading bu...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Tue, 03.11.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - November 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO W...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Mon, 02.11.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - November 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO W...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Sun, 01.11.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Fri, 30.10.2026       Azenta
US1143401024

Exclusive licensing agreement with Elegen and acquisition of SynPlexity strengthen gene synthesis capabilities, expand high-throughput discovery workflows, and position GENEWIZ for long-term growthBURLINGTON, Mass., Oct. 30, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced strategic investments to advance the next phase of growth f...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Fri, 30.10.2026       Azenta
US1143401024

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading b...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Thu, 29.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO W...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Wed, 28.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO W...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Mon, 26.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO W...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Sun, 25.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO W...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Fri, 23.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO W...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Thu, 22.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO W...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Wed, 21.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO W...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Tue, 20.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO W...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Mon, 19.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO W...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Sun, 18.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO W...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Thu, 15.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 15, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO W...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Wed, 14.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO W...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Tue, 13.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO W...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Sat, 10.10.2026       Azenta
US1143401024

NEW YORK, Oct. 10, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.So what: If you purchas...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Fri, 09.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO WH...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Thu, 08.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO WH...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Wed, 07.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.SO WH...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Tue, 06.10.2026       Azenta
US1143401024

NEW YORK, Oct. 5, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.So what: If you pur...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Sun, 04.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public....
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Sat, 03.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public....
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Fri, 02.10.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - October 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public....
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Thu, 01.10.2026       Azenta
US1143401024

NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether Azenta and certain of its officers and/or director...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Tue, 29.09.2026       Azenta
US1143401024

NEW YORK, Sept. 28, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially mislea...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Sat, 26.09.2026       Azenta
US1143401024

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.So What: If you purchased Azenta securities you may be en...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Thu, 24.09.2026       Azenta
US1143401024

NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigati...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Thu, 17.09.2026       Azenta
US1143401024

NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigati...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Thu, 10.09.2026       Azenta
US1143401024

NEW YORK, Sept. 10, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigati...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Fri, 04.09.2026       Azenta
US1143401024

BURLINGTON, Mass., Sept. 4, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has received repayment in full, prior to maturity, of the $35 million secured vendor loan extended in connection with the previously announced sale of B Medical Systems S.à r.l. to Thelema S.à r.l.As part of the transaction, which closed on July 1,...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Thu, 03.09.2026       Azenta
US1143401024

NEW YORK, Sept. 3, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Thu, 27.08.2026       Azenta
US1143401024

NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Mon, 24.08.2026       Azenta
US1143401024

Current Director Dr. Martin Madaus Appointed Interim CEOCompany Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue GuidanceBURLINGTON, Mass., Aug. 24, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. Martin Madaus has be...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Tue, 04.08.2026       Azenta
US1143401024

BURLINGTON, Mass., Aug. 4, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2026. The results of B Medical Systems are reported as discontinued operations and reflected in total diluted EPS. The Company entered into a definitive agreement to sell the business during fiscal 2025,...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Wed, 22.07.2026       Azenta
US1143401024

BURLINGTON, Mass., July 22, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2026 earnings which ended on June 30, 2026, on Tuesday, August 4, 2026, after the market closes.The Company will host a conference call and live webcast to discuss its financial results the following day, Wednesday, August 5, 2026, at 8:...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Wed, 08.07.2026       Azenta
US1143401024

BURLINGTON, Mass., July 8, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the completion of the previously disclosed sale of its B Medical Systems business to Thelema S.à r.l.The transaction was originally announced on December 29, 2025 and closed on July 1, 2026 following the satisfaction of all closing conditions. Under the ter...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Thu, 04.06.2026       Azenta
US1143401024

NEW YORK, June 4, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Thu, 28.05.2026       Azenta
US1143401024

NEW YORK, May 28, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Wed, 27.05.2026       Azenta
US1143401024

Azenta, Inc. reaffirmed 3%-5% organic revenue growth and 300 basis points of margin expansion in February 2026 -- then cut both targets three months later after recording a $149 million goodwill impairment.NEW YORK, May 27, 2026 /PRNewswire/ -- Shareholders who purchased Azenta, Inc. (NASDAQ: AZTA) stock lost significant value after the Company sl...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Mon, 25.05.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - May 25, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Azenta, Inc. (NASDAQ: AZTA) ("Azenta, Inc.") concerning potential violations of the federal securities laws.On February 4, 2026, CEO John Marotta told investors Azenta was "entering the year well positioned for c...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Fri, 22.05.2026       Azenta
US1143401024

Law Offices of Howard G. Smith continues its investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA) investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN AZENTA, INC. (AZTA), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLA...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Fri, 22.05.2026       Azenta
US1143401024

The Law Offices of Frank R. Cruz continues its investigation of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA) on behalf of investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON AZENTA, INC. (AZTA), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Fri, 22.05.2026       Azenta
US1143401024

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA) investors concerning the Company’s possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON AZENTA, INC. (AZTA), CLICK HERE TO INQU...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Thu, 21.05.2026       Azenta
US1143401024

BURLINGTON, Mass., May 21, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, demonstrating continued progress against its key ESG priorities. The report includes ESG data for the Company's fiscal year ended September 30, 2025.The report offers a co...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Thu, 21.05.2026       Azenta
US1143401024

NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink
Mon, 18.05.2026       Azenta
US1143401024

New York, New York--(Newsfile Corp. - May 18, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Azenta, Inc. (NASDAQ: AZTA) ("Azenta, Inc.") concerning potential violations of the federal securities laws.On February 4, 2026, CEO John Marotta told investors Azenta was "entering the year well positi...
Read more
Azenta
Technical Analysis Termsheets Terminal
Permalink